Bilateral Hypoglossal Nerve Stimulation (BHGNS) therapy for sleep apnea
740-779-8700How BHGNS therapy works
BHGNS received FDA approval in August 2025, making it one of the most recently cleared treatments for obstructive sleep apnea. Adena is proud to be among the first providers in the region offering access to this technology.
Obstructive sleep apnea happens when the tongue and throat muscles relax during sleep and block the airway. BHGNS therapy addresses this directly by stimulating the hypoglossal nerve — the nerve that controls tongue movement.
A small nerve-stimulation device is placed under the chin through a single tiny incision. During sleep, the device delivers gentle, precise stimulation to both branches of the hypoglossal nerve, nudging the tongue forward slightly to keep your airway open at night. The stimulation it works on both sides of the tongue at once, which is a key difference from other nerve stimulation devices.
To power the implant, you wear a small patch on your chin at bedtime and clip a lightweight activation chip to it. The activation chip provides the power supply externally, which is what allows the implant itself to be completely battery-free. When you wake up, you remove the chip and patch.
BHGNS vs. HGNS
Both BHGNS and HGNS are FDA-approved implants that treat obstructive sleep apnea by stimulating the tongue nerve. They work on the same principle but differ in design, placement, and clinical profile. Your doctor will help determine which is the better fit for you.
| Central sleep apnea (CSA) | Obstructive sleep apnea (OSA) | |
|---|---|---|
| Battery inside the body | No | Yes |
| Incision location | Under the chin (single) | Near the collarbone |
| Nerve stimulation | Bilateral (both sides) | Unilateral (one side) |
| Full-body MRI compatible | Yes | Requires physician discussion |
| External component during sleep | Small patch on the chin | Remote control to turn on/off |
| Works with complete concentric collapse | Yes | No |
| AHI range | 15 to 65 | 15 to 100 |
| BMI threshold | 35 or less | Under 40 |
| FDA approved | August 2025 | 2014 |
Who is BHGNS therapy for?
BHGNS is FDA-approved for adults with moderate to severe obstructive sleep apnea who have tried CPAP and found it did not work or they could not tolerate it. Your doctor will review your sleep study results, anatomy, and health history to confirm you are a good candidate.
How it works
Your sleep medicine team will review your sleep study, health history, and anatomy to confirm you are a good candidate for BHGNS. A drug-induced sleep endoscopy may be recommended to evaluate how your airway behaves during sleep before proceeding.
The BHGNS device is placed under the chin through a single small incision during a short outpatient procedure. The surgery is minimally invasive and performed by a surgeon trained in the technique.
Most patients go home the same day. The device is activated after a healing period of about two months. Your care team will work with you to fine-tune the stimulation settings to find what works best for your anatomy and sleep patterns.
Frequently asked questions
Ready to explore a new option?
We are at the forefront of sleep apnea care in the region, and BHGNS therapy is one of the ways we are bringing the latest innovations directly to our patients. If CPAP has not been the right fit or you have questions about BHGNS therapy, our sleep medicine team is here to help. Call us to schedule a consultation and find out if you are a candidate.
Call Adena Sleep Medicine: 740-779-8700